Additional treatment not effective to treat pancreatic cancer
Median overall survival was 11.9 months in patients receiving gemcitabine plus erlotinib.
Pancreatic Diseases
Optimized medical therapy linked to long-term relief in chronic pancreatitis
Nearly 85% of patients achieved significant pain relief at 1-year follow up.
Pediatric pancreatitis associated with repeat hospitalizations, high costs
Children with recurrent acute or chronic pancreatitis are likely to have high healthcare costs and a high risk for repeat hospitalization.
Acute or chronic pancreatitis?
How can a clinician distinguish chronic pancreatitis from acute pancreatitis in a patient with alcohol-abuse history?
Obesity linked to worse survival in pancreatic CA
Higher prediagnostic BMI also linked to more advanced disease at diagnosis.
Two pancreatic-enzyme drugs approved
The FDA has approved Ultresa and Viokace to aid food digestion in patients with pancreatic enzyme deficiencies.
